文献速递类风湿关节炎

RAID评分与其它患者报告结局及疾病活动度指标的反应性比较:ARCTIC研究二次分析

Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC study.
PubMed 文献 · RMD Open · 2018-10-26

该研究基于ARCTIC试验中230例早期未使用改善病情抗风湿药的RA患者,随访24个月,比较RAID评分与其它PROMs、炎症标志物及临床疾病活动度指标的反应性。结果显示RAID在3个月和6个月均具有高反应性(SRM≥0.80),且比RAI压痛关节数及多数其它PROMs更敏感地检测变化。

要点

  • RAID评分在早期RA患者中3个月和6个月均显示高反应性(SRM≥0.80)。
  • RAID检测变化的能力优于参考指标RAI压痛关节数及多数其它PROMs。
  • 该研究为ARCTIC试验二次分析,患者为未使用DMARDs的早期RA。

核心结论

  • RAID评分对接受达标治疗策略的短病程RA患者的变化具有高度反应性。
  • RAID在检测变化方面比参考指标RAI及多数其它PROMs更有效。

研究设计与样本

  • ARCTIC试验的二次分析,纳入未使用改善病情抗风湿药的早期RA患者,随访24个月。
  • 共纳入230例RA患者,平均±SD症状病程7.1±5.4个月,基线RAID评分均值±SD为4.49±2.14。

主要发现

  • 随访3个月时RAID变化均值±SD为-2.25±1.98,SRM(95%CI)为-1.13(-1.33至-0.96)。
  • RAID评分在3个月和6个月均显示高反应性(SRM≥0.80)。
  • RAID比参考指标RAI压痛关节数更敏感地检测变化。

关键数值与推荐

  • SRM大于0.80被视为高反应性。
  • 反应性评估采用标准化反应均值(SRM)和相对效率(RE),参考指标为Ritchie关节指数(RAI)压痛关节数。

临床怎么用

  • 在早期RA达标治疗随访中,RAID评分可作为敏感的患者报告结局工具监测疾病影响变化。
  • RAID在检测变化方面优于RAI压痛关节数及多数其它PROMs,支持其用于临床评估。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the responsiveness of the Rheumatoid Arthritis Impact of Disease (RAID) score compared with other patient-reported outcome measures (PROMs), inflammatory markers and clinical disease activity measures in patients with early rheumatoid arthritis (RA). METHODS: Disease-modifying antirheumatic drug-naïve patients with RA with short disease duration were included in the treat-to-target ARCTIC trial and followed for 24 months. The responsiveness of the RAID score was evaluated using standardised response mean (SRM) and relative efficiency (RE) with respect to tender joints by Ritchie Articular Index (RAI). SRMs and REs were also calculated for other PROMs, inflammatory markers and clinical outcome measures. An SRM with value above 0.80 was considered high. RESULTS: 230 patients with RA were included. The mean±SD symptom duration was 7.1±5.4 months and the baseline mean±SD RAID score was 4.49±2.14. At 3 months of follow-up, the mean±SD change score for RAID was -2.25±1.98 and the SRM (95% CI) -1.13 (-1.33 to -0.96). The RAID score showed high responsiveness both at 3 and 6 months (SRM≥0.80) and was more sensitive in detecting change than the reference, tender joints assessed by RAI. CONCLUSIONS: The RAID score proved to be highly responsive to change in patients with RA with short disease duration who followed a treat-to-target strategy. The RAID score was more efficient in detecting change than the reference (RAI) as well as most other PROMs.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Holten K, Sexton J, Kvien TK, et al. Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC study. RMD Open. 2018. PMID: 30487996. doi:10.1136/rmdopen-2018-000754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。